Table 1.
Descriptive characteristics.
| Overt SSRI (n = 24) |
Covert SSRI (n = 22) |
Statistic (df) |
p | |
|---|---|---|---|---|
| Age, years, mean (sd) | 31.0 (10.6) | 32.0 (9.7) | t(44) = 0.33 | 0.74 |
| Sex, men, n (%) | 15 (62.5) | 13 (59.1) | χ2(1) = 0.06 | 0.81 |
| Civil status, single, n (%) | 12 (50) | 7 (31.8) | χ2(1) = 1.57 | 0.21 |
| Education > 12 years, n (%) | 12 (50) | 7 (31.8) | χ2(1) = 1.57 | 0.21 |
| Comorbidity, n (%) | 9 (37.5) | 13 (59.1) | χ2(1) = 2.14 | 0.14 |
| GAD | 1 (4.2) | 4 (18.2) | ||
| Panic disorder | – | 1 (4.5) | ||
| Agoraphobia | 6 (25) | 5 (22.7) | ||
| OCD, mild | 1 (4.2) | – | ||
| Depression, mild | 5 (20.8) | 5 (22.7) | ||
| Dysthymia | 2 (8.3) | 2 (9.1) | ||
| Earlier psychological treatment, n (%) | 10 (41.7) | 9 (40.9) | χ2(1) = 0.00 | 0.96 |
| Earlier psychotropic medication, n (%) | 4 (16.7) | 7 (31.8) | χ2(1) = 1.45 | 0.23 |
| SSRIs | 4 (16.7) | 6 (27.3) | ||
| Venlafaxine | – | 1 (4.5) |
GAD = generalized anxiety disorder, OCD = obsessive compulsive disorder, SSRI = selective serotonin reuptake inhibitor.